nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—NTRK1—Sunitinib—kidney cancer	0.121	0.204	CbGbCtD
Amitriptyline—ABCB1—kidney cancer	0.0816	1	CbGaD
Amitriptyline—ORM1—Erlotinib—kidney cancer	0.0341	0.0576	CbGbCtD
Amitriptyline—CYP3A5—Temsirolimus—kidney cancer	0.0308	0.0519	CbGbCtD
Amitriptyline—ABCB1—Temsirolimus—kidney cancer	0.02	0.0338	CbGbCtD
Amitriptyline—HTR2C—Sorafenib—kidney cancer	0.0192	0.0324	CbGbCtD
Amitriptyline—CYP2D6—Temsirolimus—kidney cancer	0.0189	0.0318	CbGbCtD
Amitriptyline—CYP3A4—Everolimus—kidney cancer	0.0178	0.03	CbGbCtD
Amitriptyline—CYP2C8—Pazopanib—kidney cancer	0.0156	0.0262	CbGbCtD
Amitriptyline—ALB—Erlotinib—kidney cancer	0.0144	0.0242	CbGbCtD
Amitriptyline—CYP1A2—Pazopanib—kidney cancer	0.012	0.0203	CbGbCtD
Amitriptyline—CYP3A4—Temsirolimus—kidney cancer	0.012	0.0203	CbGbCtD
Amitriptyline—CYP2B6—Sorafenib—kidney cancer	0.0119	0.0201	CbGbCtD
Amitriptyline—CYP3A5—Erlotinib—kidney cancer	0.0115	0.0195	CbGbCtD
Amitriptyline—CYP2C9—Capecitabine—kidney cancer	0.0113	0.0191	CbGbCtD
Amitriptyline—CYP2C8—Erlotinib—kidney cancer	0.0111	0.0187	CbGbCtD
Amitriptyline—CYP3A5—Paclitaxel—kidney cancer	0.0106	0.0178	CbGbCtD
Amitriptyline—ABCB1—Pazopanib—kidney cancer	0.0105	0.0178	CbGbCtD
Amitriptyline—CYP2C8—Paclitaxel—kidney cancer	0.0102	0.0171	CbGbCtD
Amitriptyline—CYP2D6—Pazopanib—kidney cancer	0.00992	0.0167	CbGbCtD
Amitriptyline—ABCB1—Dactinomycin—kidney cancer	0.00963	0.0162	CbGbCtD
Amitriptyline—CYP3A5—Sorafenib—kidney cancer	0.00938	0.0158	CbGbCtD
Amitriptyline—CYP3A5—Vincristine—kidney cancer	0.00911	0.0154	CbGbCtD
Amitriptyline—CYP2C8—Sorafenib—kidney cancer	0.00902	0.0152	CbGbCtD
Amitriptyline—CYP1A2—Erlotinib—kidney cancer	0.00859	0.0145	CbGbCtD
Amitriptyline—ABCB1—Gemcitabine—kidney cancer	0.00761	0.0128	CbGbCtD
Amitriptyline—CYP3A5—Sunitinib—kidney cancer	0.0076	0.0128	CbGbCtD
Amitriptyline—CYP2C19—Sorafenib—kidney cancer	0.00757	0.0128	CbGbCtD
Amitriptyline—ABCB1—Erlotinib—kidney cancer	0.00751	0.0127	CbGbCtD
Amitriptyline—CYP2B6—Doxorubicin—kidney cancer	0.00723	0.0122	CbGbCtD
Amitriptyline—CYP2C9—Paclitaxel—kidney cancer	0.00709	0.0119	CbGbCtD
Amitriptyline—CYP2D6—Erlotinib—kidney cancer	0.00708	0.0119	CbGbCtD
Amitriptyline—CYP1A2—Sorafenib—kidney cancer	0.00698	0.0118	CbGbCtD
Amitriptyline—CHRM3—ureter—kidney cancer	0.00698	0.153	CbGeAlD
Amitriptyline—ABCB1—Paclitaxel—kidney cancer	0.00688	0.0116	CbGbCtD
Amitriptyline—CYP3A4—Pazopanib—kidney cancer	0.00631	0.0106	CbGbCtD
Amitriptyline—CYP2C9—Sorafenib—kidney cancer	0.00629	0.0106	CbGbCtD
Amitriptyline—ABCB1—Sorafenib—kidney cancer	0.00611	0.0103	CbGbCtD
Amitriptyline—ABCB1—Vinblastine—kidney cancer	0.00603	0.0102	CbGbCtD
Amitriptyline—ABCB1—Vincristine—kidney cancer	0.00593	0.01	CbGbCtD
Amitriptyline—CYP2D6—Sorafenib—kidney cancer	0.00576	0.00971	CbGbCtD
Amitriptyline—CYP2D6—Vinblastine—kidney cancer	0.00568	0.00958	CbGbCtD
Amitriptyline—ABCB1—Sunitinib—kidney cancer	0.00495	0.00835	CbGbCtD
Amitriptyline—CYP3A4—Erlotinib—kidney cancer	0.0045	0.00759	CbGbCtD
Amitriptyline—CYP3A4—Paclitaxel—kidney cancer	0.00412	0.00695	CbGbCtD
Amitriptyline—ABCB1—Doxorubicin—kidney cancer	0.00371	0.00625	CbGbCtD
Amitriptyline—CYP3A4—Sorafenib—kidney cancer	0.00366	0.00617	CbGbCtD
Amitriptyline—CYP3A4—Vinblastine—kidney cancer	0.00361	0.00609	CbGbCtD
Amitriptyline—CYP3A4—Vincristine—kidney cancer	0.00355	0.00599	CbGbCtD
Amitriptyline—CYP2D6—Doxorubicin—kidney cancer	0.00349	0.00589	CbGbCtD
Amitriptyline—Olopatadine—S100A1—kidney cancer	0.00305	0.628	CrCbGaD
Amitriptyline—CYP3A4—Sunitinib—kidney cancer	0.00297	0.005	CbGbCtD
Amitriptyline—CYP3A4—Doxorubicin—kidney cancer	0.00222	0.00374	CbGbCtD
Amitriptyline—CYP2C19—urine—kidney cancer	0.00211	0.0463	CbGeAlD
Amitriptyline—NTRK2—gonad—kidney cancer	0.00208	0.0455	CbGeAlD
Amitriptyline—CYP1A2—urine—kidney cancer	0.00172	0.0378	CbGeAlD
Amitriptyline—CYP2C9—urine—kidney cancer	0.00163	0.0359	CbGeAlD
Amitriptyline—CYP2E1—urine—kidney cancer	0.00155	0.034	CbGeAlD
Amitriptyline—KCNQ2—gonad—kidney cancer	0.00145	0.0318	CbGeAlD
Amitriptyline—HTR2A—urine—kidney cancer	0.00135	0.0295	CbGeAlD
Amitriptyline—KCND3—cortex of kidney—kidney cancer	0.00126	0.0275	CbGeAlD
Amitriptyline—CYP3A4—urine—kidney cancer	0.00125	0.0273	CbGeAlD
Amitriptyline—CYP2D6—urine—kidney cancer	0.00123	0.0269	CbGeAlD
Amitriptyline—KCND3—cardiac atrium—kidney cancer	0.00119	0.0262	CbGeAlD
Amitriptyline—OPRD1—renal system—kidney cancer	0.0011	0.0241	CbGeAlD
Amitriptyline—OPRD1—kidney—kidney cancer	0.00106	0.0233	CbGeAlD
Amitriptyline—HRH2—cardiac atrium—kidney cancer	0.00093	0.0204	CbGeAlD
Amitriptyline—ADRA1B—renal system—kidney cancer	0.000907	0.0199	CbGeAlD
Amitriptyline—ADRA1B—kidney—kidney cancer	0.000877	0.0192	CbGeAlD
Amitriptyline—Dimetacrine—ACHE—kidney cancer	0.000811	0.167	CrCbGaD
Amitriptyline—SIGMAR1—nephron tubule—kidney cancer	0.00068	0.0149	CbGeAlD
Amitriptyline—HTR1D—kidney—kidney cancer	0.000641	0.0141	CbGeAlD
Amitriptyline—SIGMAR1—cortex of kidney—kidney cancer	0.000582	0.0128	CbGeAlD
Amitriptyline—CHRM3—renal system—kidney cancer	0.000555	0.0122	CbGeAlD
Amitriptyline—SIGMAR1—cardiac atrium—kidney cancer	0.000554	0.0121	CbGeAlD
Amitriptyline—HTR1A—renal system—kidney cancer	0.000553	0.0121	CbGeAlD
Amitriptyline—CHRM3—kidney—kidney cancer	0.000537	0.0118	CbGeAlD
Amitriptyline—HTR7—renal system—kidney cancer	0.000528	0.0116	CbGeAlD
Amitriptyline—HTR7—kidney—kidney cancer	0.000511	0.0112	CbGeAlD
Amitriptyline—ADRA1A—renal system—kidney cancer	0.00051	0.0112	CbGeAlD
Amitriptyline—SLC6A2—gonad—kidney cancer	0.000491	0.0108	CbGeAlD
Amitriptyline—HTR7—gonad—kidney cancer	0.000474	0.0104	CbGeAlD
Amitriptyline—CYP2C8—renal system—kidney cancer	0.00045	0.00988	CbGeAlD
Amitriptyline—CYP3A5—nephron tubule—kidney cancer	0.000447	0.00981	CbGeAlD
Amitriptyline—CYP2B6—nephron tubule—kidney cancer	0.000444	0.00975	CbGeAlD
Amitriptyline—CYP2C8—kidney—kidney cancer	0.000435	0.00955	CbGeAlD
Amitriptyline—CYP1A2—renal system—kidney cancer	0.000421	0.00924	CbGeAlD
Amitriptyline—CYP2E1—nephron tubule—kidney cancer	0.000417	0.00915	CbGeAlD
Amitriptyline—CYP3A5—renal system—kidney cancer	0.000406	0.00891	CbGeAlD
Amitriptyline—CYP2B6—renal system—kidney cancer	0.000404	0.00886	CbGeAlD
Amitriptyline—CYP3A5—kidney—kidney cancer	0.000393	0.00862	CbGeAlD
Amitriptyline—CYP2B6—kidney—kidney cancer	0.00039	0.00857	CbGeAlD
Amitriptyline—CYP3A5—cortex of kidney—kidney cancer	0.000383	0.00839	CbGeAlD
Amitriptyline—CYP2E1—renal system—kidney cancer	0.000379	0.00831	CbGeAlD
Amitriptyline—CYP2E1—kidney—kidney cancer	0.000366	0.00804	CbGeAlD
Amitriptyline—ADRA2A—cortex of kidney—kidney cancer	0.000365	0.008	CbGeAlD
Amitriptyline—CYP2B6—gonad—kidney cancer	0.000362	0.00795	CbGeAlD
Amitriptyline—CYP2E1—cortex of kidney—kidney cancer	0.000357	0.00783	CbGeAlD
Amitriptyline—ADRA2A—gonad—kidney cancer	0.000347	0.00762	CbGeAlD
Amitriptyline—ADRA2A—cardiac atrium—kidney cancer	0.000347	0.00761	CbGeAlD
Amitriptyline—HTR2A—renal system—kidney cancer	0.000329	0.00723	CbGeAlD
Amitriptyline—HTR2A—kidney—kidney cancer	0.000318	0.00699	CbGeAlD
Amitriptyline—CYP3A4—renal system—kidney cancer	0.000305	0.00669	CbGeAlD
Amitriptyline—CYP2D6—renal system—kidney cancer	0.0003	0.00658	CbGeAlD
Amitriptyline—HTR2A—gonad—kidney cancer	0.000295	0.00648	CbGeAlD
Amitriptyline—CYP3A4—kidney—kidney cancer	0.000295	0.00647	CbGeAlD
Amitriptyline—CYP2D6—kidney—kidney cancer	0.00029	0.00636	CbGeAlD
Amitriptyline—Clomipramine—GSTP1—kidney cancer	0.000238	0.0489	CrCbGaD
Amitriptyline—ABCB1—nephron tubule—kidney cancer	0.000237	0.00521	CbGeAlD
Amitriptyline—ABCB1—renal system—kidney cancer	0.000216	0.00474	CbGeAlD
Amitriptyline—ABCB1—kidney—kidney cancer	0.000209	0.00458	CbGeAlD
Amitriptyline—ABCB1—cortex of kidney—kidney cancer	0.000203	0.00446	CbGeAlD
Amitriptyline—Acute coronary syndrome—Capecitabine—kidney cancer	0.000198	0.00127	CcSEcCtD
Amitriptyline—Hypertension—Gemcitabine—kidney cancer	0.000197	0.00127	CcSEcCtD
Amitriptyline—Myocardial infarction—Capecitabine—kidney cancer	0.000197	0.00126	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Capecitabine—kidney cancer	0.000197	0.00126	CcSEcCtD
Amitriptyline—Pruritus—Everolimus—kidney cancer	0.000197	0.00126	CcSEcCtD
Amitriptyline—Oedema—Vincristine—kidney cancer	0.000197	0.00126	CcSEcCtD
Amitriptyline—Arrhythmia—Paclitaxel—kidney cancer	0.000196	0.00126	CcSEcCtD
Amitriptyline—Jaundice—Capecitabine—kidney cancer	0.000196	0.00126	CcSEcCtD
Amitriptyline—Stomatitis—Capecitabine—kidney cancer	0.000196	0.00126	CcSEcCtD
Amitriptyline—Alopecia—Paclitaxel—kidney cancer	0.000194	0.00125	CcSEcCtD
Amitriptyline—ABCB1—gonad—kidney cancer	0.000194	0.00425	CbGeAlD
Amitriptyline—Asthenia—Erlotinib—kidney cancer	0.000193	0.00124	CcSEcCtD
Amitriptyline—Thrombocytopenia—Vincristine—kidney cancer	0.000192	0.00124	CcSEcCtD
Amitriptyline—Discomfort—Gemcitabine—kidney cancer	0.000192	0.00123	CcSEcCtD
Amitriptyline—Urticaria—Sorafenib—kidney cancer	0.000192	0.00123	CcSEcCtD
Amitriptyline—Decreased appetite—Dactinomycin—kidney cancer	0.000191	0.00123	CcSEcCtD
Amitriptyline—Diarrhoea—Vinblastine—kidney cancer	0.000191	0.00123	CcSEcCtD
Amitriptyline—Body temperature increased—Sorafenib—kidney cancer	0.000191	0.00123	CcSEcCtD
Amitriptyline—Diarrhoea—Everolimus—kidney cancer	0.00019	0.00122	CcSEcCtD
Amitriptyline—Hyperhidrosis—Vincristine—kidney cancer	0.00019	0.00122	CcSEcCtD
Amitriptyline—Pruritus—Erlotinib—kidney cancer	0.00019	0.00122	CcSEcCtD
Amitriptyline—Fatigue—Dactinomycin—kidney cancer	0.00019	0.00122	CcSEcCtD
Amitriptyline—Vascular purpura—Doxorubicin—kidney cancer	0.000188	0.00121	CcSEcCtD
Amitriptyline—Agranulocytosis—Capecitabine—kidney cancer	0.000187	0.0012	CcSEcCtD
Amitriptyline—Anorexia—Vincristine—kidney cancer	0.000187	0.0012	CcSEcCtD
Amitriptyline—Dysgeusia—Paclitaxel—kidney cancer	0.000187	0.0012	CcSEcCtD
Amitriptyline—Hepatic failure—Doxorubicin—kidney cancer	0.000187	0.0012	CcSEcCtD
Amitriptyline—Oedema—Gemcitabine—kidney cancer	0.000186	0.0012	CcSEcCtD
Amitriptyline—Dizziness—Vinblastine—kidney cancer	0.000185	0.00119	CcSEcCtD
Amitriptyline—Dizziness—Everolimus—kidney cancer	0.000184	0.00118	CcSEcCtD
Amitriptyline—Body temperature increased—Sunitinib—kidney cancer	0.000184	0.00118	CcSEcCtD
Amitriptyline—Diarrhoea—Erlotinib—kidney cancer	0.000184	0.00118	CcSEcCtD
Amitriptyline—Hypotension—Vincristine—kidney cancer	0.000184	0.00118	CcSEcCtD
Amitriptyline—Thrombocytopenia—Gemcitabine—kidney cancer	0.000183	0.00117	CcSEcCtD
Amitriptyline—Feeling abnormal—Dactinomycin—kidney cancer	0.000181	0.00116	CcSEcCtD
Amitriptyline—Hepatitis—Capecitabine—kidney cancer	0.00018	0.00116	CcSEcCtD
Amitriptyline—Vision blurred—Paclitaxel—kidney cancer	0.00018	0.00116	CcSEcCtD
Amitriptyline—Hyperhidrosis—Gemcitabine—kidney cancer	0.00018	0.00116	CcSEcCtD
Amitriptyline—Hypoaesthesia—Capecitabine—kidney cancer	0.000179	0.00115	CcSEcCtD
Amitriptyline—Tremor—Paclitaxel—kidney cancer	0.000179	0.00115	CcSEcCtD
Amitriptyline—Insomnia—Vincristine—kidney cancer	0.000178	0.00114	CcSEcCtD
Amitriptyline—Anorexia—Gemcitabine—kidney cancer	0.000178	0.00114	CcSEcCtD
Amitriptyline—Vomiting—Vinblastine—kidney cancer	0.000178	0.00114	CcSEcCtD
Amitriptyline—Dizziness—Erlotinib—kidney cancer	0.000178	0.00114	CcSEcCtD
Amitriptyline—Ill-defined disorder—Paclitaxel—kidney cancer	0.000177	0.00114	CcSEcCtD
Amitriptyline—Vomiting—Everolimus—kidney cancer	0.000177	0.00114	CcSEcCtD
Amitriptyline—Paraesthesia—Vincristine—kidney cancer	0.000177	0.00113	CcSEcCtD
Amitriptyline—Agitation—Paclitaxel—kidney cancer	0.000176	0.00113	CcSEcCtD
Amitriptyline—Rash—Everolimus—kidney cancer	0.000175	0.00113	CcSEcCtD
Amitriptyline—Dermatitis—Everolimus—kidney cancer	0.000175	0.00113	CcSEcCtD
Amitriptyline—Headache—Vinblastine—kidney cancer	0.000175	0.00112	CcSEcCtD
Amitriptyline—Purpura—Doxorubicin—kidney cancer	0.000174	0.00112	CcSEcCtD
Amitriptyline—Headache—Everolimus—kidney cancer	0.000174	0.00112	CcSEcCtD
Amitriptyline—Hypotension—Gemcitabine—kidney cancer	0.000174	0.00112	CcSEcCtD
Amitriptyline—Body temperature increased—Dactinomycin—kidney cancer	0.000174	0.00112	CcSEcCtD
Amitriptyline—Asthenia—Sorafenib—kidney cancer	0.000173	0.00111	CcSEcCtD
Amitriptyline—Malaise—Paclitaxel—kidney cancer	0.000173	0.00111	CcSEcCtD
Amitriptyline—Syncope—Paclitaxel—kidney cancer	0.000172	0.0011	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000171	0.0011	CcSEcCtD
Amitriptyline—Leukopenia—Paclitaxel—kidney cancer	0.000171	0.0011	CcSEcCtD
Amitriptyline—Decreased appetite—Vincristine—kidney cancer	0.000171	0.0011	CcSEcCtD
Amitriptyline—Pruritus—Sorafenib—kidney cancer	0.000171	0.0011	CcSEcCtD
Amitriptyline—Vomiting—Erlotinib—kidney cancer	0.000171	0.0011	CcSEcCtD
Amitriptyline—Fatigue—Vincristine—kidney cancer	0.000169	0.00109	CcSEcCtD
Amitriptyline—Rash—Erlotinib—kidney cancer	0.000169	0.00109	CcSEcCtD
Amitriptyline—Dermatitis—Erlotinib—kidney cancer	0.000169	0.00109	CcSEcCtD
Amitriptyline—Palpitations—Paclitaxel—kidney cancer	0.000169	0.00109	CcSEcCtD
Amitriptyline—Insomnia—Gemcitabine—kidney cancer	0.000169	0.00108	CcSEcCtD
Amitriptyline—Headache—Erlotinib—kidney cancer	0.000168	0.00108	CcSEcCtD
Amitriptyline—Tinnitus—Capecitabine—kidney cancer	0.000168	0.00108	CcSEcCtD
Amitriptyline—Loss of consciousness—Paclitaxel—kidney cancer	0.000168	0.00108	CcSEcCtD
Amitriptyline—Constipation—Vincristine—kidney cancer	0.000168	0.00108	CcSEcCtD
Amitriptyline—Osteoarthritis—Doxorubicin—kidney cancer	0.000168	0.00108	CcSEcCtD
Amitriptyline—Paraesthesia—Gemcitabine—kidney cancer	0.000167	0.00108	CcSEcCtD
Amitriptyline—Asthenia—Sunitinib—kidney cancer	0.000167	0.00107	CcSEcCtD
Amitriptyline—Nausea—Vinblastine—kidney cancer	0.000166	0.00107	CcSEcCtD
Amitriptyline—Somnolence—Gemcitabine—kidney cancer	0.000166	0.00106	CcSEcCtD
Amitriptyline—Convulsion—Paclitaxel—kidney cancer	0.000166	0.00106	CcSEcCtD
Amitriptyline—Nausea—Everolimus—kidney cancer	0.000165	0.00106	CcSEcCtD
Amitriptyline—Diarrhoea—Sorafenib—kidney cancer	0.000165	0.00106	CcSEcCtD
Amitriptyline—Hypertension—Paclitaxel—kidney cancer	0.000165	0.00106	CcSEcCtD
Amitriptyline—Pruritus—Sunitinib—kidney cancer	0.000164	0.00106	CcSEcCtD
Amitriptyline—Anxiety—Paclitaxel—kidney cancer	0.000162	0.00104	CcSEcCtD
Amitriptyline—Decreased appetite—Gemcitabine—kidney cancer	0.000162	0.00104	CcSEcCtD
Amitriptyline—Arrhythmia—Capecitabine—kidney cancer	0.000161	0.00103	CcSEcCtD
Amitriptyline—Discomfort—Paclitaxel—kidney cancer	0.000161	0.00103	CcSEcCtD
Amitriptyline—Fatigue—Gemcitabine—kidney cancer	0.000161	0.00103	CcSEcCtD
Amitriptyline—Dizziness—Sorafenib—kidney cancer	0.00016	0.00103	CcSEcCtD
Amitriptyline—Constipation—Gemcitabine—kidney cancer	0.000159	0.00102	CcSEcCtD
Amitriptyline—Nausea—Erlotinib—kidney cancer	0.000159	0.00102	CcSEcCtD
Amitriptyline—Alopecia—Capecitabine—kidney cancer	0.000159	0.00102	CcSEcCtD
Amitriptyline—Dry mouth—Paclitaxel—kidney cancer	0.000159	0.00102	CcSEcCtD
Amitriptyline—Diarrhoea—Sunitinib—kidney cancer	0.000159	0.00102	CcSEcCtD
Amitriptyline—Ataxia—Doxorubicin—kidney cancer	0.000158	0.00101	CcSEcCtD
Amitriptyline—Asthenia—Dactinomycin—kidney cancer	0.000158	0.00101	CcSEcCtD
Amitriptyline—Confusional state—Paclitaxel—kidney cancer	0.000157	0.00101	CcSEcCtD
Amitriptyline—Oedema—Paclitaxel—kidney cancer	0.000156	0.001	CcSEcCtD
Amitriptyline—Body temperature increased—Vincristine—kidney cancer	0.000155	0.000998	CcSEcCtD
Amitriptyline—Dysgeusia—Capecitabine—kidney cancer	0.000154	0.000987	CcSEcCtD
Amitriptyline—Dizziness—Sunitinib—kidney cancer	0.000154	0.000987	CcSEcCtD
Amitriptyline—Feeling abnormal—Gemcitabine—kidney cancer	0.000154	0.000987	CcSEcCtD
Amitriptyline—Shock—Paclitaxel—kidney cancer	0.000154	0.000987	CcSEcCtD
Amitriptyline—Vomiting—Sorafenib—kidney cancer	0.000154	0.000986	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000153	0.000986	CcSEcCtD
Amitriptyline—Thrombocytopenia—Paclitaxel—kidney cancer	0.000153	0.000982	CcSEcCtD
Amitriptyline—Tachycardia—Paclitaxel—kidney cancer	0.000152	0.000979	CcSEcCtD
Amitriptyline—Rash—Sorafenib—kidney cancer	0.000152	0.000978	CcSEcCtD
Amitriptyline—Dermatitis—Sorafenib—kidney cancer	0.000152	0.000977	CcSEcCtD
Amitriptyline—Headache—Sorafenib—kidney cancer	0.000151	0.000972	CcSEcCtD
Amitriptyline—Hyperhidrosis—Paclitaxel—kidney cancer	0.000151	0.000969	CcSEcCtD
Amitriptyline—Diarrhoea—Dactinomycin—kidney cancer	0.000151	0.000967	CcSEcCtD
Amitriptyline—Anorexia—Paclitaxel—kidney cancer	0.000149	0.000956	CcSEcCtD
Amitriptyline—Vision blurred—Capecitabine—kidney cancer	0.000148	0.00095	CcSEcCtD
Amitriptyline—Vomiting—Sunitinib—kidney cancer	0.000148	0.000949	CcSEcCtD
Amitriptyline—Body temperature increased—Gemcitabine—kidney cancer	0.000147	0.000947	CcSEcCtD
Amitriptyline—Tremor—Capecitabine—kidney cancer	0.000147	0.000945	CcSEcCtD
Amitriptyline—Rash—Sunitinib—kidney cancer	0.000147	0.000941	CcSEcCtD
Amitriptyline—Dermatitis—Sunitinib—kidney cancer	0.000146	0.00094	CcSEcCtD
Amitriptyline—Hypotension—Paclitaxel—kidney cancer	0.000146	0.000937	CcSEcCtD
Amitriptyline—Ill-defined disorder—Capecitabine—kidney cancer	0.000146	0.000936	CcSEcCtD
Amitriptyline—Headache—Sunitinib—kidney cancer	0.000146	0.000935	CcSEcCtD
Amitriptyline—Eosinophilia—Doxorubicin—kidney cancer	0.000144	0.000924	CcSEcCtD
Amitriptyline—Nausea—Sorafenib—kidney cancer	0.000143	0.000921	CcSEcCtD
Amitriptyline—Malaise—Capecitabine—kidney cancer	0.000142	0.000909	CcSEcCtD
Amitriptyline—Insomnia—Paclitaxel—kidney cancer	0.000141	0.000907	CcSEcCtD
Amitriptyline—Asthenia—Vincristine—kidney cancer	0.000141	0.000906	CcSEcCtD
Amitriptyline—Syncope—Capecitabine—kidney cancer	0.000141	0.000904	CcSEcCtD
Amitriptyline—Leukopenia—Capecitabine—kidney cancer	0.000141	0.000903	CcSEcCtD
Amitriptyline—Paraesthesia—Paclitaxel—kidney cancer	0.00014	0.0009	CcSEcCtD
Amitriptyline—Vomiting—Dactinomycin—kidney cancer	0.00014	0.000898	CcSEcCtD
Amitriptyline—Somnolence—Paclitaxel—kidney cancer	0.000139	0.000891	CcSEcCtD
Amitriptyline—Palpitations—Capecitabine—kidney cancer	0.000139	0.000891	CcSEcCtD
Amitriptyline—Rash—Dactinomycin—kidney cancer	0.000139	0.000891	CcSEcCtD
Amitriptyline—Nausea—Sunitinib—kidney cancer	0.000138	0.000887	CcSEcCtD
Amitriptyline—Loss of consciousness—Capecitabine—kidney cancer	0.000138	0.000886	CcSEcCtD
Amitriptyline—Pancytopenia—Doxorubicin—kidney cancer	0.000138	0.000886	CcSEcCtD
Amitriptyline—Dyspepsia—Paclitaxel—kidney cancer	0.000137	0.000883	CcSEcCtD
Amitriptyline—Decreased appetite—Paclitaxel—kidney cancer	0.000136	0.000872	CcSEcCtD
Amitriptyline—Hypertension—Capecitabine—kidney cancer	0.000136	0.000871	CcSEcCtD
Amitriptyline—Fatigue—Paclitaxel—kidney cancer	0.000135	0.000865	CcSEcCtD
Amitriptyline—Diarrhoea—Vincristine—kidney cancer	0.000134	0.000864	CcSEcCtD
Amitriptyline—Pollakiuria—Doxorubicin—kidney cancer	0.000134	0.000862	CcSEcCtD
Amitriptyline—Asthenia—Gemcitabine—kidney cancer	0.000134	0.000859	CcSEcCtD
Amitriptyline—Constipation—Paclitaxel—kidney cancer	0.000134	0.000858	CcSEcCtD
Amitriptyline—Anxiety—Capecitabine—kidney cancer	0.000133	0.000855	CcSEcCtD
Amitriptyline—Weight increased—Doxorubicin—kidney cancer	0.000132	0.000849	CcSEcCtD
Amitriptyline—Discomfort—Capecitabine—kidney cancer	0.000132	0.000848	CcSEcCtD
Amitriptyline—Pruritus—Gemcitabine—kidney cancer	0.000132	0.000847	CcSEcCtD
Amitriptyline—Dry mouth—Capecitabine—kidney cancer	0.000131	0.00084	CcSEcCtD
Amitriptyline—Nausea—Dactinomycin—kidney cancer	0.000131	0.000839	CcSEcCtD
Amitriptyline—Dizziness—Vincristine—kidney cancer	0.00013	0.000835	CcSEcCtD
Amitriptyline—Drowsiness—Doxorubicin—kidney cancer	0.000129	0.000832	CcSEcCtD
Amitriptyline—Confusional state—Capecitabine—kidney cancer	0.000129	0.00083	CcSEcCtD
Amitriptyline—Feeling abnormal—Paclitaxel—kidney cancer	0.000129	0.000826	CcSEcCtD
Amitriptyline—Nortriptyline—PTGS1—kidney cancer	0.000129	0.0264	CrCbGaD
Amitriptyline—Oedema—Capecitabine—kidney cancer	0.000128	0.000823	CcSEcCtD
Amitriptyline—Diarrhoea—Gemcitabine—kidney cancer	0.000128	0.00082	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000127	0.000815	CcSEcCtD
Amitriptyline—Stomatitis—Doxorubicin—kidney cancer	0.000126	0.000811	CcSEcCtD
Amitriptyline—Jaundice—Doxorubicin—kidney cancer	0.000126	0.000811	CcSEcCtD
Amitriptyline—Shock—Capecitabine—kidney cancer	0.000126	0.00081	CcSEcCtD
Amitriptyline—Thrombocytopenia—Capecitabine—kidney cancer	0.000125	0.000806	CcSEcCtD
Amitriptyline—Tachycardia—Capecitabine—kidney cancer	0.000125	0.000803	CcSEcCtD
Amitriptyline—Vomiting—Vincristine—kidney cancer	0.000125	0.000803	CcSEcCtD
Amitriptyline—Urticaria—Paclitaxel—kidney cancer	0.000124	0.000797	CcSEcCtD
Amitriptyline—Rash—Vincristine—kidney cancer	0.000124	0.000796	CcSEcCtD
Amitriptyline—Hyperhidrosis—Capecitabine—kidney cancer	0.000124	0.000796	CcSEcCtD
Amitriptyline—Dermatitis—Vincristine—kidney cancer	0.000124	0.000795	CcSEcCtD
Amitriptyline—Body temperature increased—Paclitaxel—kidney cancer	0.000123	0.000793	CcSEcCtD
Amitriptyline—Headache—Vincristine—kidney cancer	0.000123	0.000791	CcSEcCtD
Amitriptyline—Anorexia—Capecitabine—kidney cancer	0.000122	0.000784	CcSEcCtD
Amitriptyline—Epinastine—ABCB1—kidney cancer	0.000121	0.0248	CrCbGaD
Amitriptyline—Agranulocytosis—Doxorubicin—kidney cancer	0.000121	0.000776	CcSEcCtD
Amitriptyline—Hypotension—Capecitabine—kidney cancer	0.00012	0.000769	CcSEcCtD
Amitriptyline—Diphenhydramine—PTGS1—kidney cancer	0.000119	0.0244	CrCbGaD
Amitriptyline—Vomiting—Gemcitabine—kidney cancer	0.000119	0.000762	CcSEcCtD
Amitriptyline—Rash—Gemcitabine—kidney cancer	0.000118	0.000755	CcSEcCtD
Amitriptyline—Dermatitis—Gemcitabine—kidney cancer	0.000117	0.000754	CcSEcCtD
Amitriptyline—Headache—Gemcitabine—kidney cancer	0.000117	0.00075	CcSEcCtD
Amitriptyline—Nausea—Vincristine—kidney cancer	0.000117	0.00075	CcSEcCtD
Amitriptyline—Hepatitis—Doxorubicin—kidney cancer	0.000116	0.000747	CcSEcCtD
Amitriptyline—Insomnia—Capecitabine—kidney cancer	0.000116	0.000744	CcSEcCtD
Amitriptyline—Hypoaesthesia—Doxorubicin—kidney cancer	0.000116	0.000743	CcSEcCtD
Amitriptyline—Paraesthesia—Capecitabine—kidney cancer	0.000115	0.000739	CcSEcCtD
Amitriptyline—Dyspepsia—Capecitabine—kidney cancer	0.000113	0.000724	CcSEcCtD
Amitriptyline—Asthenia—Paclitaxel—kidney cancer	0.000112	0.000719	CcSEcCtD
Amitriptyline—Decreased appetite—Capecitabine—kidney cancer	0.000111	0.000715	CcSEcCtD
Amitriptyline—Nausea—Gemcitabine—kidney cancer	0.000111	0.000711	CcSEcCtD
Amitriptyline—Fatigue—Capecitabine—kidney cancer	0.00011	0.000709	CcSEcCtD
Amitriptyline—Pruritus—Paclitaxel—kidney cancer	0.00011	0.000709	CcSEcCtD
Amitriptyline—Constipation—Capecitabine—kidney cancer	0.00011	0.000704	CcSEcCtD
Amitriptyline—Tinnitus—Doxorubicin—kidney cancer	0.000108	0.000696	CcSEcCtD
Amitriptyline—Diarrhoea—Paclitaxel—kidney cancer	0.000107	0.000686	CcSEcCtD
Amitriptyline—Feeling abnormal—Capecitabine—kidney cancer	0.000106	0.000678	CcSEcCtD
Amitriptyline—Arrhythmia—Doxorubicin—kidney cancer	0.000104	0.000667	CcSEcCtD
Amitriptyline—Dizziness—Paclitaxel—kidney cancer	0.000103	0.000663	CcSEcCtD
Amitriptyline—Alopecia—Doxorubicin—kidney cancer	0.000103	0.00066	CcSEcCtD
Amitriptyline—Urticaria—Capecitabine—kidney cancer	0.000102	0.000654	CcSEcCtD
Amitriptyline—Body temperature increased—Capecitabine—kidney cancer	0.000101	0.000651	CcSEcCtD
Amitriptyline—Vomiting—Paclitaxel—kidney cancer	9.93e-05	0.000638	CcSEcCtD
Amitriptyline—Dysgeusia—Doxorubicin—kidney cancer	9.91e-05	0.000637	CcSEcCtD
Amitriptyline—Rash—Paclitaxel—kidney cancer	9.84e-05	0.000632	CcSEcCtD
Amitriptyline—Dermatitis—Paclitaxel—kidney cancer	9.84e-05	0.000632	CcSEcCtD
Amitriptyline—Headache—Paclitaxel—kidney cancer	9.78e-05	0.000628	CcSEcCtD
Amitriptyline—Vision blurred—Doxorubicin—kidney cancer	9.54e-05	0.000613	CcSEcCtD
Amitriptyline—Ill-defined disorder—Doxorubicin—kidney cancer	9.39e-05	0.000603	CcSEcCtD
Amitriptyline—Agitation—Doxorubicin—kidney cancer	9.3e-05	0.000597	CcSEcCtD
Amitriptyline—Nausea—Paclitaxel—kidney cancer	9.27e-05	0.000596	CcSEcCtD
Amitriptyline—Asthenia—Capecitabine—kidney cancer	9.19e-05	0.00059	CcSEcCtD
Amitriptyline—Malaise—Doxorubicin—kidney cancer	9.13e-05	0.000586	CcSEcCtD
Amitriptyline—Syncope—Doxorubicin—kidney cancer	9.08e-05	0.000583	CcSEcCtD
Amitriptyline—Pruritus—Capecitabine—kidney cancer	9.06e-05	0.000582	CcSEcCtD
Amitriptyline—Leukopenia—Doxorubicin—kidney cancer	9.06e-05	0.000582	CcSEcCtD
Amitriptyline—Palpitations—Doxorubicin—kidney cancer	8.94e-05	0.000574	CcSEcCtD
Amitriptyline—Loss of consciousness—Doxorubicin—kidney cancer	8.89e-05	0.000571	CcSEcCtD
Amitriptyline—Convulsion—Doxorubicin—kidney cancer	8.77e-05	0.000563	CcSEcCtD
Amitriptyline—Diarrhoea—Capecitabine—kidney cancer	8.77e-05	0.000563	CcSEcCtD
Amitriptyline—Hypertension—Doxorubicin—kidney cancer	8.74e-05	0.000561	CcSEcCtD
Amitriptyline—Anxiety—Doxorubicin—kidney cancer	8.59e-05	0.000551	CcSEcCtD
Amitriptyline—Discomfort—Doxorubicin—kidney cancer	8.51e-05	0.000547	CcSEcCtD
Amitriptyline—Dizziness—Capecitabine—kidney cancer	8.47e-05	0.000544	CcSEcCtD
Amitriptyline—Dry mouth—Doxorubicin—kidney cancer	8.43e-05	0.000541	CcSEcCtD
Amitriptyline—Confusional state—Doxorubicin—kidney cancer	8.33e-05	0.000535	CcSEcCtD
Amitriptyline—Oedema—Doxorubicin—kidney cancer	8.26e-05	0.00053	CcSEcCtD
Amitriptyline—Vomiting—Capecitabine—kidney cancer	8.15e-05	0.000523	CcSEcCtD
Amitriptyline—Shock—Doxorubicin—kidney cancer	8.13e-05	0.000522	CcSEcCtD
Amitriptyline—Thrombocytopenia—Doxorubicin—kidney cancer	8.09e-05	0.000519	CcSEcCtD
Amitriptyline—Rash—Capecitabine—kidney cancer	8.08e-05	0.000519	CcSEcCtD
Amitriptyline—Dermatitis—Capecitabine—kidney cancer	8.07e-05	0.000518	CcSEcCtD
Amitriptyline—Tachycardia—Doxorubicin—kidney cancer	8.06e-05	0.000518	CcSEcCtD
Amitriptyline—Headache—Capecitabine—kidney cancer	8.03e-05	0.000516	CcSEcCtD
Amitriptyline—Hyperhidrosis—Doxorubicin—kidney cancer	7.98e-05	0.000513	CcSEcCtD
Amitriptyline—Anorexia—Doxorubicin—kidney cancer	7.87e-05	0.000506	CcSEcCtD
Amitriptyline—Hypotension—Doxorubicin—kidney cancer	7.72e-05	0.000496	CcSEcCtD
Amitriptyline—Nausea—Capecitabine—kidney cancer	7.61e-05	0.000489	CcSEcCtD
Amitriptyline—Insomnia—Doxorubicin—kidney cancer	7.47e-05	0.00048	CcSEcCtD
Amitriptyline—Paraesthesia—Doxorubicin—kidney cancer	7.42e-05	0.000476	CcSEcCtD
Amitriptyline—Somnolence—Doxorubicin—kidney cancer	7.34e-05	0.000472	CcSEcCtD
Amitriptyline—Dyspepsia—Doxorubicin—kidney cancer	7.27e-05	0.000467	CcSEcCtD
Amitriptyline—Decreased appetite—Doxorubicin—kidney cancer	7.18e-05	0.000461	CcSEcCtD
Amitriptyline—Fatigue—Doxorubicin—kidney cancer	7.12e-05	0.000457	CcSEcCtD
Amitriptyline—Constipation—Doxorubicin—kidney cancer	7.06e-05	0.000454	CcSEcCtD
Amitriptyline—Feeling abnormal—Doxorubicin—kidney cancer	6.81e-05	0.000437	CcSEcCtD
Amitriptyline—Urticaria—Doxorubicin—kidney cancer	6.56e-05	0.000421	CcSEcCtD
Amitriptyline—Body temperature increased—Doxorubicin—kidney cancer	6.53e-05	0.000419	CcSEcCtD
Amitriptyline—Clomipramine—ABCB1—kidney cancer	6.4e-05	0.0131	CrCbGaD
Amitriptyline—Chlorprothixene—ABCB1—kidney cancer	6.37e-05	0.0131	CrCbGaD
Amitriptyline—Asthenia—Doxorubicin—kidney cancer	5.93e-05	0.000381	CcSEcCtD
Amitriptyline—Trimipramine—ABCB1—kidney cancer	5.89e-05	0.0121	CrCbGaD
Amitriptyline—Pruritus—Doxorubicin—kidney cancer	5.84e-05	0.000375	CcSEcCtD
Amitriptyline—Promethazine—ABCB1—kidney cancer	5.67e-05	0.0116	CrCbGaD
Amitriptyline—Diarrhoea—Doxorubicin—kidney cancer	5.65e-05	0.000363	CcSEcCtD
Amitriptyline—Doxepin—ABCB1—kidney cancer	5.61e-05	0.0115	CrCbGaD
Amitriptyline—Dizziness—Doxorubicin—kidney cancer	5.46e-05	0.000351	CcSEcCtD
Amitriptyline—Vomiting—Doxorubicin—kidney cancer	5.25e-05	0.000337	CcSEcCtD
Amitriptyline—Rash—Doxorubicin—kidney cancer	5.21e-05	0.000334	CcSEcCtD
Amitriptyline—Dermatitis—Doxorubicin—kidney cancer	5.2e-05	0.000334	CcSEcCtD
Amitriptyline—Headache—Doxorubicin—kidney cancer	5.17e-05	0.000332	CcSEcCtD
Amitriptyline—Desipramine—ABCB1—kidney cancer	5.15e-05	0.0106	CrCbGaD
Amitriptyline—Nausea—Doxorubicin—kidney cancer	4.91e-05	0.000315	CcSEcCtD
Amitriptyline—Imipramine—ABCB1—kidney cancer	4.37e-05	0.00897	CrCbGaD
Amitriptyline—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	2.66e-06	2.23e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	2.66e-06	2.23e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—RELA—kidney cancer	2.66e-06	2.23e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—RAF1—kidney cancer	2.65e-06	2.22e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—RELA—kidney cancer	2.65e-06	2.22e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MTOR—kidney cancer	2.65e-06	2.22e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—RAF1—kidney cancer	2.65e-06	2.22e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MYC—kidney cancer	2.64e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—RELA—kidney cancer	2.64e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—ERBB2—kidney cancer	2.64e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	2.64e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL2—kidney cancer	2.64e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—ERBB2—kidney cancer	2.63e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—RELA—kidney cancer	2.63e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTGS2—kidney cancer	2.63e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	2.63e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—KRAS—kidney cancer	2.63e-06	2.2e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—ERBB2—kidney cancer	2.63e-06	2.2e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—RAF1—kidney cancer	2.62e-06	2.2e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—ERBB2—kidney cancer	2.62e-06	2.19e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—RAF1—kidney cancer	2.61e-06	2.19e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—RELA—kidney cancer	2.61e-06	2.19e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.61e-06	2.18e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PTEN—kidney cancer	2.61e-06	2.18e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MTOR—kidney cancer	2.61e-06	2.18e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—RELA—kidney cancer	2.6e-06	2.18e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MTOR—kidney cancer	2.6e-06	2.18e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PTEN—kidney cancer	2.59e-06	2.17e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—ERBB2—kidney cancer	2.59e-06	2.17e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MTOR—kidney cancer	2.59e-06	2.17e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MAPK1—kidney cancer	2.59e-06	2.17e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	2.58e-06	2.17e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MTOR—kidney cancer	2.58e-06	2.16e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MAPK3—kidney cancer	2.58e-06	2.16e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTGS2—kidney cancer	2.58e-06	2.16e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTGS2—kidney cancer	2.57e-06	2.16e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CCND1—kidney cancer	2.57e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—JUN—kidney cancer	2.57e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MTOR—kidney cancer	2.56e-06	2.14e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MAPK3—kidney cancer	2.55e-06	2.14e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MAPK3—kidney cancer	2.55e-06	2.14e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MTOR—kidney cancer	2.55e-06	2.14e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—KRAS—kidney cancer	2.55e-06	2.14e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	2.55e-06	2.13e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—PIK3CA—kidney cancer	2.52e-06	2.11e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MYC—kidney cancer	2.51e-06	2.1e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.51e-06	2.1e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—POMC—kidney cancer	2.49e-06	2.09e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MYC—kidney cancer	2.48e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MYC—kidney cancer	2.48e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CDKN1B—kidney cancer	2.48e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—PIK3CA—kidney cancer	2.48e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PTEN—kidney cancer	2.48e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—PIK3CA—kidney cancer	2.48e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	2.46e-06	2.07e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MAPK1—kidney cancer	2.45e-06	2.06e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PTEN—kidney cancer	2.45e-06	2.05e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	2.45e-06	2.05e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	2.44e-06	2.05e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—KRAS—kidney cancer	2.44e-06	2.05e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CDKN1B—kidney cancer	2.44e-06	2.04e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TP53—kidney cancer	2.44e-06	2.04e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—POMC—kidney cancer	2.43e-06	2.04e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	2.43e-06	2.04e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL2—kidney cancer	2.43e-06	2.04e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MAPK1—kidney cancer	2.43e-06	2.04e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MAPK1—kidney cancer	2.43e-06	2.04e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—RAF1—kidney cancer	2.43e-06	2.03e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	2.42e-06	2.03e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—RELA—kidney cancer	2.42e-06	2.03e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	2.41e-06	2.02e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TP53—kidney cancer	2.4e-06	2.01e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	2.4e-06	2.01e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	2.4e-06	2.01e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TP53—kidney cancer	2.4e-06	2.01e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	2.39e-06	2.01e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL2—kidney cancer	2.39e-06	2.01e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL2—kidney cancer	2.39e-06	2e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TP53—kidney cancer	2.38e-06	2e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL2—kidney cancer	2.38e-06	1.99e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL2—kidney cancer	2.37e-06	1.99e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CCND1—kidney cancer	2.37e-06	1.99e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MTOR—kidney cancer	2.37e-06	1.99e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—JUN—kidney cancer	2.37e-06	1.98e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—VEGFA—kidney cancer	2.35e-06	1.97e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL2—kidney cancer	2.35e-06	1.97e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CTNNB1—kidney cancer	2.35e-06	1.97e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—PIK3CA—kidney cancer	2.34e-06	1.96e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL2—kidney cancer	2.34e-06	1.96e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—VEGFA—kidney cancer	2.34e-06	1.96e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TP53—kidney cancer	2.33e-06	1.96e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CCND1—kidney cancer	2.33e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—JUN—kidney cancer	2.33e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CCND1—kidney cancer	2.33e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—JUN—kidney cancer	2.32e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CCND1—kidney cancer	2.32e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—KRAS—kidney cancer	2.32e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—JUN—kidney cancer	2.31e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CCND1—kidney cancer	2.31e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	2.31e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSTP1—kidney cancer	2.31e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—JUN—kidney cancer	2.31e-06	1.93e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CTNNB1—kidney cancer	2.3e-06	1.93e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	2.3e-06	1.93e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTEN—kidney cancer	2.3e-06	1.92e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—KRAS—kidney cancer	2.3e-06	1.92e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—KRAS—kidney cancer	2.3e-06	1.92e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—POMC—kidney cancer	2.29e-06	1.92e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CCND1—kidney cancer	2.29e-06	1.92e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	2.29e-06	1.92e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PTEN—kidney cancer	2.29e-06	1.92e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—JUN—kidney cancer	2.29e-06	1.92e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CCND1—kidney cancer	2.28e-06	1.91e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—JUN—kidney cancer	2.28e-06	1.91e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—POMC—kidney cancer	2.27e-06	1.91e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	2.27e-06	1.9e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—kidney cancer	2.27e-06	1.9e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	2.26e-06	1.9e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PTEN—kidney cancer	2.25e-06	1.89e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTEN—kidney cancer	2.25e-06	1.88e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PTEN—kidney cancer	2.25e-06	1.88e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTEN—kidney cancer	2.24e-06	1.88e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	2.24e-06	1.88e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	2.24e-06	1.88e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PTEN—kidney cancer	2.24e-06	1.88e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PTEN—kidney cancer	2.23e-06	1.87e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTGS2—kidney cancer	2.23e-06	1.87e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MAPK3—kidney cancer	2.23e-06	1.87e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	2.22e-06	1.86e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTGS2—kidney cancer	2.22e-06	1.86e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MAPK3—kidney cancer	2.21e-06	1.86e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PTEN—kidney cancer	2.21e-06	1.85e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PTEN—kidney cancer	2.2e-06	1.85e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ABCB1—kidney cancer	2.19e-06	1.83e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL2—kidney cancer	2.18e-06	1.82e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—kidney cancer	2.17e-06	1.82e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—kidney cancer	2.17e-06	1.81e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—kidney cancer	2.15e-06	1.81e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.14e-06	1.79e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—PIK3CA—kidney cancer	2.13e-06	1.78e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSTM1—kidney cancer	2.12e-06	1.78e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCND1—kidney cancer	2.12e-06	1.78e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	2.12e-06	1.78e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MAPK1—kidney cancer	2.12e-06	1.78e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—JUN—kidney cancer	2.12e-06	1.77e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—PIK3CA—kidney cancer	2.11e-06	1.77e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—PIK3CA—kidney cancer	2.11e-06	1.77e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MAPK1—kidney cancer	2.11e-06	1.77e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	2.1e-06	1.76e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—kidney cancer	2.07e-06	1.73e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—kidney cancer	2.06e-06	1.73e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—kidney cancer	2.06e-06	1.73e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PTEN—kidney cancer	2.05e-06	1.72e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—kidney cancer	2.04e-06	1.71e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—kidney cancer	2.04e-06	1.71e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—kidney cancer	2.03e-06	1.7e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—kidney cancer	2.03e-06	1.7e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—kidney cancer	2.02e-06	1.69e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	2.02e-06	1.69e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—kidney cancer	2.02e-06	1.69e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.01e-06	1.69e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KRAS—kidney cancer	2e-06	1.68e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—kidney cancer	2e-06	1.67e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	1.99e-06	1.67e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KRAS—kidney cancer	1.99e-06	1.67e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—kidney cancer	1.99e-06	1.67e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MAPK3—kidney cancer	1.95e-06	1.64e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTEN—kidney cancer	1.94e-06	1.63e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—POMC—kidney cancer	1.94e-06	1.63e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—kidney cancer	1.94e-06	1.63e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTEN—kidney cancer	1.93e-06	1.62e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MAPK3—kidney cancer	1.92e-06	1.61e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MAPK3—kidney cancer	1.92e-06	1.61e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MAPK3—kidney cancer	1.91e-06	1.6e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MAPK3—kidney cancer	1.91e-06	1.6e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KRAS—kidney cancer	1.91e-06	1.6e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—kidney cancer	1.9e-06	1.59e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MAPK3—kidney cancer	1.89e-06	1.58e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	1.88e-06	1.58e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PIK3CA—kidney cancer	1.88e-06	1.58e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—kidney cancer	1.87e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—kidney cancer	1.87e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—kidney cancer	1.86e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MAPK1—kidney cancer	1.86e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—kidney cancer	1.85e-06	1.55e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	1.85e-06	1.55e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	1.84e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—kidney cancer	1.84e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—kidney cancer	1.83e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MAPK1—kidney cancer	1.83e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—kidney cancer	1.83e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	1.83e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MAPK1—kidney cancer	1.83e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MAPK1—kidney cancer	1.82e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MAPK1—kidney cancer	1.81e-06	1.52e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—kidney cancer	1.81e-06	1.52e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MAPK1—kidney cancer	1.8e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	1.79e-06	1.5e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—kidney cancer	1.78e-06	1.49e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—kidney cancer	1.77e-06	1.48e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KRAS—kidney cancer	1.76e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	1.75e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	1.75e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTEN—kidney cancer	1.74e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KRAS—kidney cancer	1.73e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PIK3CA—kidney cancer	1.73e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KRAS—kidney cancer	1.72e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KRAS—kidney cancer	1.72e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KRAS—kidney cancer	1.71e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—kidney cancer	1.7e-06	1.43e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KRAS—kidney cancer	1.7e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTEN—kidney cancer	1.69e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—kidney cancer	1.69e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KRAS—kidney cancer	1.69e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	1.66e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.62e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PIK3CA—kidney cancer	1.61e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTEN—kidney cancer	1.6e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	1.59e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.59e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PIK3CA—kidney cancer	1.58e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.58e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTEN—kidney cancer	1.58e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	1.58e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	1.57e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KRAS—kidney cancer	1.57e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—kidney cancer	1.56e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	1.56e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	1.55e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—kidney cancer	1.55e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—kidney cancer	1.54e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—kidney cancer	1.53e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—kidney cancer	1.53e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—kidney cancer	1.52e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—kidney cancer	1.51e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—kidney cancer	1.5e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—POMC—kidney cancer	1.5e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	1.44e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—kidney cancer	1.4e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.37e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CA—kidney cancer	1.36e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTEN—kidney cancer	1.35e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.22e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—kidney cancer	1.2e-06	1e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CA—kidney cancer	1.19e-06	1e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.13e-06	9.44e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.12e-06	9.35e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTEN—kidney cancer	1.04e-06	8.75e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CA—kidney cancer	9.54e-07	7.99e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.36e-07	6.17e-06	CbGpPWpGaD
